BioHarvest Sciences (BHST)
Makes plant-cell compounds for VINIA and CDMO partners.
Something off on this page? Send us feedback.
Uses plant-cell cultivation to make plant-based compounds without growing the underlying plant. Its Products business sells VINIA, while CDMO Services applies the same Botanical Synthesis platform for industry partners.
Botanical Synthesis grows plant cells to develop plant-based compounds without cultivating the source plant. The platform supports proprietary direct-to-consumer products and CDMO Services for industry partners.
VINIA, a red-grape-cell polyphenol nutraceutical, is the first proprietary commercial product. CDMO Services extends the same process to pharmaceutical, nutraceutical, cosmeceutical, and nutrition applications.
Founded in Israel in 2007, the operating business is paired with a Canadian public parent and a Nasdaq listing. Registered in Vancouver with a principal operating base in Rehovot, Israel, operations are led by co-founder and CEO Dr. Zaki Rakib.
The two routes depend on continued product commercialization and the ability to win and execute CDMO development agreements.
Company facts
Target rangeAs of Sep 22, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Aug 12, 2026 | Maxim Group | Reiterate | Rating: —Target: $12 | Target: $5 |
| Feb 19, 2026 | Roth Capital | Target | Target: — | Target: $10 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $16.2M · Total debt $17.5M · Total assets $44.6M · Shareholders' equity $19.8M
- Revenue
- $8.8M
- Operating income
- −$2.5M
- Net income
- −$3.7M
No dividends on record.
| Institutions | 9.71% | 1.68M shares | |
|---|---|---|---|
| 18 holders · as of Jun 30, 2026 | |||
| Other | 90.29% | 15.64M shares | |
| remainder | |||
17.33M company shares as of Aug 24, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Alyeska Investment Group, L.P.Institution | 3.36% | 581,441 | as of Jun 30, 2026 |
Thompson Siegel & Walmsley LLCInstitution | 2.10% | 364,008 | as of Jun 30, 2026 |
Evercore Wealth Management, LLCInstitution | 1.25% | 216,343 | as of Jun 30, 2026 |
True North Advisors, LLCInstitution | 1.08% | 187,318 | as of Jun 30, 2026 |
Magnus Financial Group LLCInstitution | 0.52% | 90,000 | as of Jun 30, 2026 |
Insider tradesForm 4
Nothing filed in the last 12 months.
- Niagen Bioscience
Science-backed healthy-aging supplements led by Tru Niagen
- LifeVantage
Direct-selling wellness supplements led by Protandim
- Natural Alternatives International
Private-label nutritional-supplement formulation and manufacturing
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| BioHarvest Sciences | $1.53 | +1.32% | $26.2M | — | — | 0.7 | +3.8% |
| Niagen Bioscience | $3.07 | −0.81% | $246.1M | 16.6 | 27.4 | 1.9 | −4.3% |
| LifeVantage | $6.11 | −1.77% | $78.5M | 15.5 | 21.1 | 0.4 | −23.1% |
| Natural Alternatives International | $1.92 | +1.05% | $11.9M | — | — | 0.1 | +22.7% |
| Median | 16.1 | 24.2 | 0.4 | −4.3% |